Complaint Counsel's Post Trial Brief - Federal Trade Commission
Complaint Counsel's Post Trial Brief - Federal Trade Commission
Complaint Counsel's Post Trial Brief - Federal Trade Commission
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
lines of evidence." CCPF ~ 280. LaMont testified that until there are clinical trals, ''we don't<br />
know" whether DCO's products would be effective in battling cancer, and that traditional use<br />
evidence does not replace human clincal trals. CCPF ~~ 366,369. Simlarly, Dews, offered as<br />
an exper in "(h)erbal formulations, specifically 7 Herb Formula," stated that anmal studies<br />
could not be extrapolated to humans. CCPF ~~ 295,301.<br />
Moreover, two of Respondents' four purorted experts -- Dews and Roy -- had not<br />
directly studied the DCO Products and were unfamliar with the cancer claims that Respondents<br />
have made about them. Dews testified that he was not prepared to talk about how the herbs in 7<br />
Herb Formula mayor may not benefit a person with cancer. CCPF ~ 408. He also stated that he<br />
did not know of any studies regarding the effectiveness of7 Herb Formula in treating, curng, or<br />
preventing cancer, or inhbiting tuor formation. CCPF iM 409-11, 413. Furerore, he was<br />
not familar with any studies fiding anticancer activity in any of the components of7 Herb<br />
Formula. CCPF iM 412,414-20.<br />
Respondents offered Roy as "an exper in the conduct of scientific research and with the<br />
focus on health and materals." CCPF ~ 302. Roy and his laboratory do "zero clinical trals"<br />
and "have nothg to do with causing healing or not in a human being." CCPF iM 308-09. Roy<br />
has never done any experments to measure the effcacy of any medical treatments "at the human<br />
level," and has not measured the effcacy of the DCO Products. CCPF iM 310-11. He testified<br />
that he "had no idea" what the DCO Products contain, and had not done any literatue searches<br />
or research concerng any of the ingredients in the DCO Products. CCPF iM 312-13.<br />
Respondents' two remainng expers, Duke and LaMont, who did indeed review the DCO<br />
Products' ingredients, echoed Dr. Miler's conclusions. Duke, who stated that he made no effort<br />
to see whether there were any studies of any sort regarding the DCO Products, testified that he<br />
29
Change language